Class II · Moderate riskTerminated Initiated Dec 6, 2021 (5 years ago)
Dexamethasone sodium phosphate, sterile otic solution for injection Preservative free…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Lack of Assurance of Sterility
What was recalled
Dexamethasone sodium phosphate, sterile otic solution for injection Preservative free, 19.2 mg/0.8mL (24mg/mL), 0.8 mL per syringe Single Use Syringe For Otic Injection, Edge Pharma LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-0848-01
Recalling firm
Edge Pharma, LLC
NDC code
05446-0848-01
Origin
VT, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0399-2022
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Reason Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were…